Omalizumab. An option in Vernal Keratoconjunctivitis?
COL0059567
- Autores:
-
Sánchez Caraballo, Jorge Mario
Cardona Villa, Ricardo
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2012
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/33061
- Acceso en línea:
- https://hdl.handle.net/10495/33061
- Palabra clave:
- Anti-Allergic Agents
Antialérgicos
Anticuerpos Antiidiotipos
Antibodies, Anti-Idiotypic
Anticuerpos Monoclonales Humanizados
Antibodies, Monoclonal, Humanized
Conjuntivitis Alérgica
Conjunctivitis, Allergic
Trasplante de Córnea
Corneal Transplantation
Ciclosporina
Cyclosporine
Supervivencia sin Enfermedad
Disease-Free Survival
Resistencia a Medicamentos
Drug Resistance
Omalizumab
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| id |
UDEA2_279b7d2f1e13ac6e67d8058c466ec72f |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/33061 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| title |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| spellingShingle |
Omalizumab. An option in Vernal Keratoconjunctivitis? Anti-Allergic Agents Antialérgicos Anticuerpos Antiidiotipos Antibodies, Anti-Idiotypic Anticuerpos Monoclonales Humanizados Antibodies, Monoclonal, Humanized Conjuntivitis Alérgica Conjunctivitis, Allergic Trasplante de Córnea Corneal Transplantation Ciclosporina Cyclosporine Supervivencia sin Enfermedad Disease-Free Survival Resistencia a Medicamentos Drug Resistance Omalizumab |
| title_short |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| title_full |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| title_fullStr |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| title_full_unstemmed |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| title_sort |
Omalizumab. An option in Vernal Keratoconjunctivitis? |
| dc.creator.fl_str_mv |
Sánchez Caraballo, Jorge Mario Cardona Villa, Ricardo |
| dc.contributor.author.none.fl_str_mv |
Sánchez Caraballo, Jorge Mario Cardona Villa, Ricardo |
| dc.subject.decs.none.fl_str_mv |
Anti-Allergic Agents Antialérgicos Anticuerpos Antiidiotipos Antibodies, Anti-Idiotypic Anticuerpos Monoclonales Humanizados Antibodies, Monoclonal, Humanized Conjuntivitis Alérgica Conjunctivitis, Allergic Trasplante de Córnea Corneal Transplantation Ciclosporina Cyclosporine Supervivencia sin Enfermedad Disease-Free Survival Resistencia a Medicamentos Drug Resistance Omalizumab |
| topic |
Anti-Allergic Agents Antialérgicos Anticuerpos Antiidiotipos Antibodies, Anti-Idiotypic Anticuerpos Monoclonales Humanizados Antibodies, Monoclonal, Humanized Conjuntivitis Alérgica Conjunctivitis, Allergic Trasplante de Córnea Corneal Transplantation Ciclosporina Cyclosporine Supervivencia sin Enfermedad Disease-Free Survival Resistencia a Medicamentos Drug Resistance Omalizumab |
| description |
COL0059567 |
| publishDate |
2012 |
| dc.date.issued.none.fl_str_mv |
2012 |
| dc.date.accessioned.none.fl_str_mv |
2022-12-27T16:45:51Z |
| dc.date.available.none.fl_str_mv |
2022-12-27T16:45:51Z |
| dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ARTCASO |
| dc.type.local.spa.fl_str_mv |
Reporte de caso |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.citation.spa.fl_str_mv |
Sánchez J, Cardona R. Omalizumab. An option in vernal keratoconjunctivitis? Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):319-20. doi: 10.1016/j.aller.2011.08.002. |
| dc.identifier.issn.none.fl_str_mv |
0301-0546 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/33061 |
| dc.identifier.doi.none.fl_str_mv |
10.1016/j.aller.2011.08.002 |
| dc.identifier.eissn.none.fl_str_mv |
1578-1267 |
| identifier_str_mv |
Sánchez J, Cardona R. Omalizumab. An option in vernal keratoconjunctivitis? Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):319-20. doi: 10.1016/j.aller.2011.08.002. 0301-0546 10.1016/j.aller.2011.08.002 1578-1267 |
| url |
https://hdl.handle.net/10495/33061 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Allergol. immunopatol. |
| dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
| dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.extent.spa.fl_str_mv |
2 |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Sociedad Española de Inmunología Clínica y Alergología Pediátrica |
| dc.publisher.group.spa.fl_str_mv |
Grupo de Alergología Clínica y Experimental (GACE) |
| dc.publisher.place.spa.fl_str_mv |
Murcia, España |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/3/license.txt https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/2/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/1/CardonaRicardo_2012_OmalizumabOptionVernalKeratoconjunctivitis.pdf |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 b88b088d9957e670ce3b3fbe2eedbc13 0b20c95ce6d929aa6006d5a88c59e5a9 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
| repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
| _version_ |
1812173193276817408 |
| spelling |
Sánchez Caraballo, Jorge MarioCardona Villa, Ricardo2022-12-27T16:45:51Z2022-12-27T16:45:51Z2012Sánchez J, Cardona R. Omalizumab. An option in vernal keratoconjunctivitis? Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):319-20. doi: 10.1016/j.aller.2011.08.002.0301-0546https://hdl.handle.net/10495/3306110.1016/j.aller.2011.08.0021578-12672application/pdfengSociedad Española de Inmunología Clínica y Alergología PediátricaGrupo de Alergología Clínica y Experimental (GACE)Murcia, Españainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTCASOReporte de casohttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Omalizumab. An option in Vernal Keratoconjunctivitis?Anti-Allergic AgentsAntialérgicosAnticuerpos AntiidiotiposAntibodies, Anti-IdiotypicAnticuerpos Monoclonales HumanizadosAntibodies, Monoclonal, HumanizedConjuntivitis AlérgicaConjunctivitis, AllergicTrasplante de CórneaCorneal TransplantationCiclosporinaCyclosporineSupervivencia sin EnfermedadDisease-Free SurvivalResistencia a MedicamentosDrug ResistanceOmalizumabCOL0059567Allergol. immunopatol.Allergologia et Immunopathologia319320405LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52ORIGINALCardonaRicardo_2012_OmalizumabOptionVernalKeratoconjunctivitis.pdfCardonaRicardo_2012_OmalizumabOptionVernalKeratoconjunctivitis.pdfReporte de casoapplication/pdf59059https://bibliotecadigital.udea.edu.co/bitstream/10495/33061/1/CardonaRicardo_2012_OmalizumabOptionVernalKeratoconjunctivitis.pdf0b20c95ce6d929aa6006d5a88c59e5a9MD5110495/33061oai:bibliotecadigital.udea.edu.co:10495/330612022-12-27 11:45:52.076Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |